ASTERIAS BIOTHERAPEUTICS INC's ticker is AST and the CUSIP is 04624N107. A total of 75 filers reported holding ASTERIAS BIOTHERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is 6.89 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $0 | – | 0 | – | 0.00% | – |
Q1 2021 | $0 | – | 0 | – | 0.00% | – |
Q4 2020 | $0 | – | 0 | – | 0.00% | – |
Q3 2020 | $0 | – | 0 | – | 0.00% | – |
Q2 2020 | $0 | – | 0 | – | 0.00% | – |
Q1 2020 | $0 | -100.0% | 0 | -100.0% | 0.00% | – |
Q4 2018 | $1,000 | -66.7% | 1,518 | -43.0% | 0.00% | – |
Q3 2018 | $3,000 | -25.0% | 2,665 | 0.0% | 0.00% | – |
Q2 2018 | $4,000 | +33.3% | 2,665 | +136.5% | 0.00% | – |
Q1 2018 | $3,000 | 0.0% | 1,127 | 0.0% | 0.00% | – |
Q4 2017 | $3,000 | -40.0% | 1,127 | -15.6% | 0.00% | – |
Q3 2017 | $5,000 | 0.0% | 1,335 | 0.0% | 0.00% | – |
Q2 2017 | $5,000 | 0.0% | 1,335 | 0.0% | 0.00% | – |
Q1 2017 | $5,000 | -16.7% | 1,335 | 0.0% | 0.00% | – |
Q4 2016 | $6,000 | 0.0% | 1,335 | 0.0% | 0.00% | – |
Q3 2016 | $6,000 | +100.0% | 1,335 | 0.0% | 0.00% | – |
Q2 2016 | $3,000 | -40.0% | 1,335 | -1.8% | 0.00% | – |
Q4 2015 | $5,000 | – | 1,359 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BROADWOOD CAPITAL INC | 5,292,156 | $7,144,000 | 0.82% |
Northeast Financial Consultants Inc | 732,265 | $988,000 | 0.30% |
Family Management Corp | 10,424 | $14,000 | 0.01% |
LMR Partners LLP | 81,550 | $110,000 | 0.01% |
ELEMENT CAPITAL MANAGEMENT LLC | 148,528 | $201,000 | 0.01% |
Poehling Capital Management, INC. | 3,302 | $4,000 | 0.00% |
Paloma Partners Management Co | 143,800 | $194,000 | 0.00% |
Founders Capital Management | 3,000 | $4,000 | 0.00% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 186,254 | $251,000 | 0.00% |
FNY Investment Advisers, LLC | 4,230 | $5,000 | 0.00% |